BUDIAIR

This brand name is authorized in Austria, Germany, Estonia, Lithuania, Poland, Singapore, Tunisia

Active ingredients

The drug BUDIAIR contains one active pharmaceutical ingredient (API):

1 Budesonide UNII Q3OKS62Q6X - BUDESONIDE

Budesonide is a glucocorticosteroid with a high local anti-inflammatory effect. At doses clinically equivalent to systemically acting glucocorticosteroids, budesonide gives significantly less HPA axis suppression and has a lower impact on inflammatory markers. Read about Budesonide

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
R03BA02	Budesonide	R Respiratory system → R03 Drugs for obstructive airway diseases → R03B Other drugs for obstructive airway diseases, inhalants → R03BA Glucocorticoids
Discover more medicines within R03BA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 06707634, 06707640, 06707657, 06707663, 06717816, 10116241, 12573296, 12573304, 12573310, 13889742, 13889759, 16708729, 16708735, 16708741
Country: EE	Ravimiamet	Identifier(s): 1175521
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1019003, 1019004
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100142010
Country: SG	Health Sciences Authority	Identifier(s): 13831P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 7133061, 7133062